Ultragenyx Pharmaceutical Inc. (RARE) Earnings
NASDAQ·Healthcare·Biotechnology
$15.44
+0.32%
Mkt Cap $1.59B
EPS — Estimate vs Actual
Mkt Cap
$1.59B
P/E
—
Fwd P/E
—
P/S
2.37
Rev TTM
—
EPS TTM
-$6.11
NASDAQ·Healthcare·Biotechnology
$15.44
+0.32%
Mkt Cap $1.59B
Mkt Cap
$1.59B
P/E
—
Fwd P/E
—
P/S
2.37
Rev TTM
—
EPS TTM
-$6.11